Zantac Makers Facing Lawsuits Over Carcinogen

September 26, 2019

Comments |

At A Glance

This Alert Affects:
Anyone who purchased and took Zantac.
What’s Going On?
Class action lawsuits have been filed alleging that Zantac exposes users to unsafe levels of NDMA, a chemical that the World Health Organization has described as “clearly carcinogenic.” More people who used the medicine are needed to come forward to help strengthen the litigation.
What You Can Do
If you purchased and took over-the-counter Zantac, fill out the form on this page.
How a Class Action Can Help
A class action lawsuit can help people who purchased Zantac get their money back for the medicine and require a full recall for the drug or an update to its labeling.
Contact Us